50% off Premium Yearly

NYSE:G
This summary was created by AI, based on 3 opinions in the last 12 months.
Genpact Ltd (G-N) has garnered mixed reviews from experts, emphasizing its strong historical performance and growth potential in banking and insurance services. This company has achieved an impressive 13% earnings growth over 15 years, currently trading at a PE ratio of 9.7x and a free cash flow yield of 8.5%. Despite recent challenges, including a 20% decline this year due to fears surrounding AI, these concerns are viewed as unfounded by at least one expert. However, other analysts have recommended adjusting stop losses to remain disciplined and cautious, indicating a level of stagnation in stock performance. Overall, while the company's fundamentals seem strong, the current market sentiment appears to warrant a more conservative approach.
Genpact Ltd is a American stock, trading under the symbol G (previously G-N on Stockchase) on the New York Stock Exchange (G). It is usually referred to as NYSE:G or G
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on G (previously G-N on Stockchase). 3 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Genpact Ltd.
Genpact Ltd was recommended as a Top Pick by Brendan Caldwell on 2002-07-02. Read the latest stock experts ratings for Genpact Ltd.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Genpact Ltd.
Genpact Ltd is covered by Stockchase experts and is worth watching.
On 2026-06-15, Genpact Ltd (G) stock closed at a price of $31.29.